Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Cabaletta Bio, Inc. market cap for the quarter ending 2026-08-07 was $473.03M, a 261.66% increase year-over-year.
Cabaletta Bio, Inc. market cap for the quarter ending 2026-05-07 was $648.96M, a 974.71% increase year-over-year.
Cabaletta Bio, Inc. market cap for the quarter ending 2026-03-19 was $338.98M, a 314.92% increase year-over-year.
Cabaletta Bio, Inc. market cap for the quarter ending 2025-12-31 was $221.05M, a 91.91% increase year-over-year.
Cabaletta Bio, Inc. market cap for fiscal 2026 was $473.03M.
Cabaletta Bio, Inc. market cap for fiscal 2025 was $221.05M, a 91.91% increase from fiscal 2024.
Cabaletta Bio, Inc. market cap for fiscal 2024 was $115.19M, a 89.39% decline from fiscal 2023.
Cabaletta Bio, Inc. market cap for fiscal 2023 was $1.09B, a 298.57% increase from fiscal 2022.